Dr. Mark Fleming, MD
Claim this profileVirginia Oncology Associates .
Studies Prostate Cancer
4 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Mark Fleming, MD is currently running
Lutetium (177Lu) Vipivotide Tetraxetan
for Prostate Cancer
The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after definitive therapy to their primary tumor. The data generated from this study will provide evidence for the treatment of AAA617 in early-stage prostate cancer patients to control recurrent tumor from progressing to fatal metastatic disease while preserving quality of life by delaying treatment with androgen deprivation therapy (ADT).
Recruiting2 awards Phase 36 criteria
ONC-392 + Lutetium
for Prostate Cancer
In this Phase 2 study, mCRPC patients with PSMA positive scans who progressed on prior ARTA and up to 2 lines of taxanes, and are naïve to lutetium Lu 177 vipivotide tetraxetan, will be enrolled. The study is open-label, randomized with active control, multi-center study.
Recruiting1 award Phase 1 & 2
More about Mark Fleming, MD
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mark Fleming, MD has experience with
- 177Lu-PSMA-617
- ARDT
- Lutetium Lu 177 Vipivotide Tetraxetan
- ONC-392
- 68Ga-PSMA-11
- ADT
Breakdown of trials Mark Fleming, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Fleming, MD specialize in?
Mark Fleming, MD focuses on Prostate Cancer and other conditions. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Mark Fleming, MD currently recruiting for clinical trials?
Yes, Mark Fleming, MD is currently recruiting for 2 clinical trials in Norfolk Virginia. If you're interested in participating, you should apply.
Are there any treatments that Mark Fleming, MD has studied deeply?
Yes, Mark Fleming, MD has studied treatments such as 177Lu-PSMA-617, ARDT, lutetium Lu 177 vipivotide tetraxetan.
What is the best way to schedule an appointment with Mark Fleming, MD?
Apply for one of the trials that Mark Fleming, MD is conducting.
What is the office address of Mark Fleming, MD?
The office of Mark Fleming, MD is located at: Virginia Oncology Associates ., Norfolk, Virginia 23502 United States. This is the address for their practice at the Virginia Oncology Associates ..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.